Acadia Pharmaceuticals | ACAD - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Cytokinetics USD 20.51M 4.2M 2026-06
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Incyte USD 1.39B 1.16B 2026-06
J&J USD 9.22B 1.24B 2026-06
Moderna USD 167M 6M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pfizer USD 4.58B 75M 2026-06
Prothena USD 1.94M 2.36M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.61B 135M 2026-06